CSIMarket
Ani Pharmaceuticals Inc  (ANIP)
Other Ticker:  
 
 

Ani Pharmaceuticals Inc's Yearly Income from Continued Operations Growth 5 Years

 

Select the Comparisons : Select the Ratio:



ANIP Annual Income from Cont. Operations Growth

2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change - - - - -60.67 %
Annual Income from Cont. Operations (in millions $) $18.78 $-47.90 $-42.60 $-22.55 $6.09


Annual Income from Cont. Operations Growth Comment
In the fiscal year ended 2023, company achieved Annual Income from Cont. Operations of $18.78 millions compare to loss from Cont. Operations of $-47.90 millions realized a year before.

Ani Pharmaceuticals Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2023 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2023 Annual Income from Cont. Operations
Viatris Inc -97.37 %$ 54.700  millions
Revvity Inc -64.99 %$ 179.503  millions
Envista Holdings Corporation